Specificity of lecithin:cholesterol acyltransferase and atherogenic risk: comparative studies on the plasma composition and in vitro synthesis of cholesteryl esters in 14 vertebrate species.
To determine whether the specificity of lecithin: cholesterol acyltransferase (LCAT) influences the susceptibility to atherosclerosis, we compared the composition and in vitro synthesis of cholesteryl ester (CE) in the plasmas of 14 vertebrate species with varying predisposition to atherosclerosis. The susceptible species (Group I) had significantly higher ratios of 16:0 CE/20:4 CE in their plasma than the resistant species (Group II). The in vitro formation of labeled CE species in native plasma from labeled cholesterol correlated highly with the mass composition, showing that the LCAT reaction is the predominant source of plasma CE in all the animal species examined. Isolated LCATs from Group I species also synthesized CE with higher ratios of 16:0/20:4 than LCATs from Group II when egg phosphatidylcholine (PC) was used as the acyl donor. In addition, the Group I LCATs exhibited lower specificity towards sn-2-20:4 and sn-2-22:6 PCs, and higher specificity towards sn-2-18:2 PC species than Group II LCATs. With 16:0-20:4 PC as the substrate, all Group I LCATs synthesized more 16:0 CE than 20:4 CE, whereas all Group II LCATs, with the exception of dog enzyme, synthesized predominantly 20:4 CE, showing that the two types of LCAT have different positional specificities towards this PC. These results suggest that there are two classes of LCAT in nature that differ from each other in their substrate and positional specificities, possibly because of differences in their active-site architectures. We propose that the presence of one type of LCAT, which cannot efficiently transfer certain long chain polyunsaturated acyl groups and which consequently synthesizes more saturated CE, may increase the risk of atherosclerosis.
Liu
M
M
Department of Medicine, Rush Medical College, Chicago, IL 60612, USA.
Bagdade
J D
JD
Subbaiah
P V
PV
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology*; D002645:Chickens / Q000378:metabolism; D002788:Cholesterol Esters / Q000096:biosynthesis / Q000097:blood*; D005227:Fatty Acids / Q000032:analysis; D006801:Humans; D008322:Mammals / Q000378:metabolism; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000145:classification / Q000378:metabolism*; D010713:Phosphatidylcholines / Q000378:metabolism; D012307:Risk Factors; D013045:Species Specificity; D013379:Substrate Specificity; D014714:Vertebrates / Q000378:metabolism*
D002788:Cholesterol Esters; D005227:Fatty Acids; D010713:Phosphatidylcholines; D007862:Phosphatidylcholine-Sterol O-Acyltransferase